Category: Latest News

  • Arm Shares Fall in Premarket Trade Despite Earnings and Revenue Outperformance

    Arm Shares Fall in Premarket Trade Despite Earnings and Revenue Outperformance

    Arm Holdings (NASDAQ:ARM) saw its American depositary receipts decline by more than 7% in U.S. premarket trading on Thursday, even after the semiconductor design company reported fiscal third-quarter results that exceeded analyst expectations. The company posted earnings per share of $0.43, surpassing market forecasts of $0.32. Revenue came in at $1.24 billion, slightly above the…

  • e.l.f. Beauty Shares Surge After Strong Quarterly Results and Upgraded Outlook

    e.l.f. Beauty Shares Surge After Strong Quarterly Results and Upgraded Outlook

    e.l.f. Beauty (NYSE:ELF) reported quarterly results that exceeded market expectations and increased its full-year guidance, driven by continued market share expansion and successful product introductions. Shares of the cosmetics company climbed more than 8% in premarket trading on Thursday following the announcement. The company posted third-quarter earnings per share of $1.24, significantly above the consensus…

  • Cigna Tops Q4 Profit Estimates as Revenue Growth Beats Expectations

    Cigna Tops Q4 Profit Estimates as Revenue Growth Beats Expectations

    Cigna (NYSE:CI) reported stronger-than-expected fourth-quarter results, with adjusted operating earnings reaching $8.08 per share, surpassing Bloomberg consensus forecasts of $7.88 per share. The health insurer posted adjusted revenue of $72.50 billion for the quarter, representing a 10% increase compared with the same period a year earlier and exceeding analyst expectations of $69.53 billion. Cigna’s medical…

  • Alvotech Advances Entyvio Biosimilar Program Following Successful Clinical Study

    Alvotech Advances Entyvio Biosimilar Program Following Successful Clinical Study

    Alvotech (NASDAQ:ALVO) reported positive findings from a pharmacokinetic trial evaluating AVT80, its experimental biosimilar to Entyvio, after the study successfully achieved all primary objectives. The randomized, double-blind trial compared AVT80 with Entyvio in healthy adult volunteers who received a single 108 mg subcutaneous dose. The research examined pharmacokinetics, safety, tolerability and immunogenic response of AVT80…

  • Oil Slips Over 1% as U.S.-Iran Talks Reduce Immediate Supply Fears

    Oil Slips Over 1% as U.S.-Iran Talks Reduce Immediate Supply Fears

    Oil prices declined by more than 1% on Thursday, although they remained near recent multi-month highs after the United States and Iran agreed to hold diplomatic discussions in Oman on Friday, easing short-term concerns about supply disruptions. Brent crude futures fell by 86 cents, or 1.2%, to $68.6 per barrel at 1036 GMT. Meanwhile, U.S.…

  • Silver Slides 16%, Erasing Earlier Weekly Gains

    Silver Slides 16%, Erasing Earlier Weekly Gains

    Silver prices dropped sharply during Asian trading on Thursday, leading declines across the precious metals sector as renewed selling pressure wiped out most of the metal’s recent recovery. Spot silver fell by as much as 16.7% to $73.5565 per ounce, bringing prices close to the lows recorded during last week’s sell-off. Meanwhile, silver futures for…

  • Bitcoin Falls Below $71,000 as Tech Market Weakness Weighs on Risk Assets

    Bitcoin Falls Below $71,000 as Tech Market Weakness Weighs on Risk Assets

    Bitcoin (COIN:BTCUSD) dropped sharply on Thursday, falling close to the $70,000 mark as reduced market liquidity and a widespread sell-off in global technology stocks placed renewed pressure on risk-sensitive assets. The leading cryptocurrency was down 7.6% at $70,427.1 as of 00:28 ET (05:28 GMT), marking its lowest level since early November 2024. During the session,…

  • Alphabet’s AI Spending Signals, Amazon Earnings and Central Bank Decisions Drive Market Focus: Dow Jones, S&P, Nasdaq, Wall Street Futures

    Alphabet’s AI Spending Signals, Amazon Earnings and Central Bank Decisions Drive Market Focus: Dow Jones, S&P, Nasdaq, Wall Street Futures

    U.S. stock futures suggested a mixed start to trading on Wall Street as investors evaluated major technology earnings and the continued volatility in software stocks. Alphabet (NASDAQ:GOOG) attracted particular attention after indicating it could significantly increase investment to support its artificial intelligence expansion, while market focus is also shifting toward results from e-commerce giant Amazon…

  • Nasdaq Slumps To Lowest Closing Level In Over A Month But Dow Rises

    Nasdaq Slumps To Lowest Closing Level In Over A Month But Dow Rises

    After weighing on the markets during Tuesday’s session, technology stocks showed another significant move to the downside during trading on Wednesday. The tech-heavy Nasdaq slumped to its lowest closing level in over a month after flirting with its record highs just a week. The Nasdaq ended the day off its lows of the session but…

  • Levi Strauss shares climb as Jefferies launches coverage with Buy rating

    Levi Strauss shares climb as Jefferies launches coverage with Buy rating

    Levi Strauss (NYSE:LEVI) shares rose more than 2% on Wednesday after Jefferies initiated coverage on the denim group with a Buy recommendation, citing improving market share prospects and a business mix that supports steady revenue and earnings growth. Jefferies said Levi is well positioned to deliver long-term annual revenue growth of around 4% to 5%…